Angiotensin‐converting enzyme inhibitors vs placebo or no treatment
Doubling of SCr Median · people with diabetes and kidney disease
It is very uncertain whether angiotensin‐converting‐enzyme inhibitors changes doubling of SCr Median compared with placebo or no treatment (very low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 0.69 [0.47, 1.01]8 studies · 6702 participantsVery low